SEL ICB Lambeth Community Denosumab Service
In plain English
The notice doesn't say
Who holds it now
Last won by SignHealth in Mar 2026.
- South East London (SEL) British Sign Language (BSL) NHS Talking Therapies ServiceSignHealth
- Southwark Care Home Practice QHS (Quay Health Solutions)
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 2 different firms won this buyer's 2 awards for this kind of work since 2025.
The notice as published
Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.